Financing, Equity Capital Markets

Black Diamond Therapeutics

06/23
|
$75.0 Million
BlackDiamond
Piper Sandler served as bookrunner for Black Diamond Therapeutics, Inc. on a confidentially marketed follow on offering
Sub-Type
CMFO
Sub-Sector
Biopharma